Anti-NMDA receptor encephalitis classification: Difference between revisions
Jump to navigation
Jump to search
| Line 24: | Line 24: | ||
| Class 1 | | Class 1 | ||
| Primarily | | Primarily catatonic or stuporous state | ||
| Less than 60 days | | Less than 60 days | ||
| Line 40: | Line 40: | ||
| Class 3 | | Class 3 | ||
| Primarily catatonic or stuporous | | Primarily catatonic or stuporous state | ||
| More than 60 days | | More than 60 days | ||
Revision as of 01:46, 1 January 2023
|
Anti-NMDA receptor encephalitis Microchapters |
|
Differentiating Anti-NMDA receptor encephalitis from Other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Anti-NMDA receptor encephalitis classification On the Web |
|
American Roentgen Ray Society Images of Anti-NMDA receptor encephalitis classification |
|
Directions to Hospitals Treating Anti-NMDA receptor encephalitis |
|
Risk calculators and risk factors for Anti-NMDA receptor encephalitis classification |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; AE Dheeraj Makkar, M.D.[2]
Overview
Classification
Anti NMDA Encephalitis may be classified into three subtypes, depending on the timing of presentation and duration.
| Subtype | Symptoms | Duration |
|---|---|---|
| Class 1 | Primarily catatonic or stuporous state | Less than 60 days |
| Class 2 | Primarily psychotic state | More than 60 days |
| Class 3 | Primarily catatonic or stuporous state | More than 60 days |